1. Cypress Portfolio Company, Thermi, Acquired for $80,000,000

    Thermi, a medical aesthetics technology company, was recently acquired by Spanish pharmaceutical firm Almiral for $80,000,000. Cypress initially invested in Thermi in December of 2014, providing a total of $4M in equity-preserving royalty-based growth capital across two tranches. Read More…Read More

  2. Cypress Growth Capital Closes Second Royalty-Based Investment Fund

    Texas-based Alternative Investment Manager Cypress Growth Capital Announces the Closing of Fund II at $50 Million. Dallas, TX, May 7, 2014 Cypress Growth Capital, an alternative investment management firm headquartered in Dallas, Texas, has closed its second royalty-based growth capital fund, CGC Royalty Investments II, LP. The $50,000,000 fund secured capital commitments from a premier family off…Read More